Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Ultimate Software reports higher Q1 net income, provides outlook for Q2

The Ultimate Software Group, Inc., a provider of people management solutions, has reported that net income for the first quarter ended March 31, 2013 was $4.52 million, or $0.16 per basic share, compared to $1.02 million, or $0.04 per basic share, for the same quarter ended March 31, 2012. The company expects total revenue of approximately $97 million for the second quarter of 2013.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

NewLink Genetics Q1 net loss increases

NewLink Genetics Corporation, a biopharmaceutical company, has reported that net loss attributable to the company for the first quarter ended March 31, 2013 was $7.93 million, or $0.33 loss per share, compared to a net loss attributable to the company of $4.84 million, or $0.23 loss per share, for the same quarter ended March 31, 2012.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

Maidenform reports Q1 net loss, provides guidance for 2013

Maidenform Brands, Inc., an intimate apparel company, has reported a net loss of $1.23 million, or $0.05 loss per share, for the first quarter ended March 30, 2013, compared to a net income of $5.84 million, or $0.25 per share, for the same quarter ended March 31, 2012. For 2013, the company expects earnings per share in a range of $1.20 to $1.30 and net sales in a range of $575 million to $595 million.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

BMW Group Q1 net profit decreases

BMW Group has reported that net profit for the first quarter of 2013 was E1.31 billion, or E1.99 per share, compared to E1.35 billion, or E2.05 per share, for the first quarter of 2012.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

LoJack Q1 net loss increases

LoJack Corporation, a provider of technology products and services for the tracking and recovery of stolen vehicles, motorcycles, construction equipment and cargo, has reported that net loss attributable to the company for the first quarter ended March 31, 2013 was $5.67 million, or $0.32 loss per diluted share, compared to a net loss attributable to the company of $308,000, or $0.02 loss per diluted share, for the first quarter ended March 31, 2012.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

Cisco Systems signs MoU with Saint Petersburg government

Cisco Systems, Inc., which designs, manufactures, and sells internet protocol-based networking and other products, has signed a memorandum of understanding, or MoU, with the Saint Petersburg government to expend a strategic partnership to develop and implement information and communication technologies in the city.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

General Motors Q1 net income down

General Motors Company has reported that net income attributable to common stockholders for the first quarter ended March 31, 2013 was $865 million, or $0.58 per diluted share, compared to $1 billion, or $0.60 per diluted share, for the first quarter ended March 31, 2012.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

SKP Securities Q4 net profit increases

SKP Securities Ltd., a provider of stock broking services, has reported a net profit of INR5.72 million, or INR1.02 per share, for the fourth quarter ended March 31, 2013, compared to INR3.93 million, or INR0.7 per share, for the fourth quarter ended March 31, 2012.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

Convergys reports lower Q1 net income, provides outlook for 2013

Convergys Corporation, a provider of customer management solutions, has reported that net income for the first quarter ended March 31, 2013 was $25.1 million, or $0.23 per diluted share, compared to $26.1 million, or $0.22 per diluted share, for the first quarter ended March 31, 2012. The company expects revenue to exceed $2.05 billion, and adjusted EPS to exceed $1.05 per share, for 2013.

Published By MarketLine
17 May 2013
NewsWire
NewsWire

Concert collaborates with Celgene to develop cancer and inflammation therapies

Concert Pharmaceuticals, Inc., a biotechnology company, has entered into a strategic collaboration with Celgene Corporation, a biopharmaceutical company, to develop deuterium-modified compounds targeting cancer and inflammation.

Published By MarketLine
17 May 2013

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.